Search Results - S. K. Zyryanov

Refine Results
  1. 1
    Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy

    Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy by S. K. Zyryanov, I. N. Dyakov

    Published 2024-08-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION

    EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION by S. K. Zyryanov, A. P. Pereverzev

    Published 2017-07-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Comparative pharmacoeconomic analysis of medication for patients after acute decompensated heart failure

    Comparative pharmacoeconomic analysis of medication for patients after acute decompensated heart failure by S. K. Zyryanov, E. A. Ushkalova

    Published 2020-02-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Use of gabapentin for neuropathic pain therapy: A view from perspective of evidence-based medicine

    Use of gabapentin for neuropathic pain therapy: A view from perspective of evidence-based medicine by O. I. Butranova, S. K. Zyryanov

    Published 2024-05-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    CLINICAL AND ECONOMICAL ASPECTS OF NOVEL APPROACHES TO THE TREATMENT OF CHRONIC HEART FAILURE DECOMPENSATION

    CLINICAL AND ECONOMICAL ASPECTS OF NOVEL APPROACHES TO THE TREATMENT OF CHRONIC HEART FAILURE DECOMPENSATION by S. K. Zyryanov, G. P. Arutyunov

    Published 2015-03-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy

    Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy by S. K. Zyryanov, I. N. Dyakov

    Published 2023-11-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Topical glucocorticoids in ophthalmology: a comparative analysis of efficacy and safety

    Topical glucocorticoids in ophthalmology: a comparative analysis of efficacy and safety by S. K. Zyryanov, O. I. Butranova

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Modern views on clinical and economical effectiveness of rosuvastatin

    Modern views on clinical and economical effectiveness of rosuvastatin by S. K. Zyryanov, Yu. B. Belousov

    Published 2008-02-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    A rational approach to dose reduction of CDK4/6 inhibitors in the treatment of patients with advanced breast cancer: A narrative Review

    A rational approach to dose reduction of CDK4/6 inhibitors in the treatment of patients with advanced breast cancer: A narrative Review by I. N. Dyakov, S. K. Zyryanov

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma

    Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma by S. K. Zyryanov, K. V. Orlova

    Published 2024-02-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    The Use of New Dosage Forms of Antibiotics as a Way to Improve the Effectiveness and Safety of Antibiotic Therapy

    The Use of New Dosage Forms of Antibiotics as a Way to Improve the Effectiveness and Safety of Antibiotic Therapy by S. K. Zyryanov, E. A. Baibulatova

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Rifaximin-Alpha and Other Crystalline Forms of Rifaximin: Are There Any Differences?

    Rifaximin-Alpha and Other Crystalline Forms of Rifaximin: Are There Any Differences? by S. K. Zyryanov, E. A. Baybulatova

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    New opportunities for lowering low-density lipoprotein cholesterol: comparative characteristics of PCSK9-targeted therapy

    New opportunities for lowering low-density lipoprotein cholesterol: comparative characteristics of PCSK9-targeted therapy by S. K. Zyryanov, O. I. Butranova

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy

    Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy by S. K. Zyryanov, I. N. Diyakov

    Published 2020-04-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Hypromellose in Ophthalmology

    Hypromellose in Ophthalmology by O. I. Butranova, S. K. Zyryanov

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Regulation of connective tissue development by calcium channel blocking agents in adhesion process

    Regulation of connective tissue development by calcium channel blocking agents in adhesion process by S. V. Skalskii, T. F. Sokolova, S. K. Zyryanov

    Published 2017-11-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation

    Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation by S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev

    Published 2020-02-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Pharmacokinetic analysis of meropenem therapeutic drug monitoring data (TDM) in critically ill adult patients

    Pharmacokinetic analysis of meropenem therapeutic drug monitoring data (TDM) in critically ill adult patients by I. B. Bondareva, S. K. Zyryanov, M. S. Chenkurov

    Published 2022-03-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY

    ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY by E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko

    Published 2017-03-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Predictors of infectious pathology in the neonatal period

    Predictors of infectious pathology in the neonatal period by O. A. Shulakova, K. G. Gurevitch, S. K. Zyryanov

    Published 2015-12-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: